Back
ESC Premium Access

Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction in relation to renal function: 1-year SWEDEHEART registry data.

Session: P2Y12 inhibitors in acute coronary syndromes
Topic: Thrombosis and platelets
Speaker: Doctor R. Edfors (Stockholm, SE)
Event: ESC Congress 2017

Congress Presentation

About the speaker

Doctor Robert Edfors

Karolinska University Hospital, Stockholm (Sweden)
0 follower

4 more presentations in this session

State of the Art: P2Y12 inhibitors in acute coronary syndromes

Speaker: Professor D. Bhatt (New York, US)

Access
Slides
Video
Thumbnail

Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry.

Speaker: Doctor P. Riedmaier (Ludwigshafen, DE)

Access
Abstract
Slides
Video
Thumbnail

The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction : a systematic review and meta-analysis

Speaker: Doctor A. Bellemain-Appaix (Antibes, FR)

Access
Abstract
Thumbnail

Future perspectives for antithrombotic strategy after acute coronary syndromes

Speaker: Professor R. Storey (Sheffield, GB)

Access
Slides
Video
Thumbnail

Access the full session

P2Y12 inhibitors in acute coronary syndromes

Speakers: Doctor R. Edfors, Professor D. Bhatt, Doctor P. Riedmaier, Doctor A. Bellemain-Appaix, Professor R. Storey
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb